Baloise stock holds at 219.60 CHF as earnings guide the view

Baloise stock (ISIN CH0012410517) traded at 219.60 CHF on September 21, 2026, after falling 0.8 percent to 219.60 CHF in SIX SX trading, with 31,965 shares changing hands by 12:28 p.m. The 52-week range stood at 183.40 CHF to 226.60 CHF, and the stock was 3.09 percent below its September 17, 2026 high.

Profit still frames the case

According to ad hoc news on September 20, 2026, Baloise's most recent annual report for fiscal year 2025 showed a clearly positive net profit and solid premium income. The same report backdrop also points to stable underwriting results and investment income as the main earnings drivers.

The market is therefore still reading the shares through the lens of fiscal year 2025, not a fresh quarterly update. That matters for investors because the latest reported figures remain the reference point for profit, dividend capacity and capital strength.

Capital and payout matter

ad hoc news also said on September 20, 2026 that Baloise communicated a robust capital position, with solvency comfortably above minimum requirements in the most recently reported period. It added that the dividend for the last completed fiscal year remains an important benchmark for shareholders.

For a Swiss insurer, that mix is the key number set: 219.60 CHF on September 21, 2026, 31,965 shares traded by 12:28 p.m., and a 52-week high of 226.60 CHF from September 17, 2026. Add the fiscal year 2025 profit backdrop, and the stock is being judged more on earnings quality and capital resilience than on a single trading headline.

Stock stays near the peak

Baloise stock closed the latest quoted session at 219.60 CHF on SIX Swiss Exchange, while the 52-week low remained 183.40 CHF and the high 226.60 CHF. The move leaves the shares close to the top of their yearly range.

More news and analyses on Baloise stock